• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Timeliness of End-of-Life Discussions for Blood Cancers: A National Survey of Hematologic Oncologists.

作者信息

Odejide Oreofe O, Cronin Angel M, Condron Nolan, Earle Craig C, Wolfe Joanne, Abel Gregory A

机构信息

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts2Center for Lymphoma, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

出版信息

JAMA Intern Med. 2016 Feb;176(2):263-5. doi: 10.1001/jamainternmed.2015.6599.

DOI:10.1001/jamainternmed.2015.6599
PMID:26720644
Abstract
摘要

相似文献

1
Timeliness of End-of-Life Discussions for Blood Cancers: A National Survey of Hematologic Oncologists.血液系统恶性肿瘤临终讨论的及时性：血液肿瘤学家的全国性调查。
JAMA Intern Med. 2016 Feb;176(2):263-5. doi: 10.1001/jamainternmed.2015.6599.
2
How Do Blood Cancer Doctors Discuss Prognosis? Findings from a National Survey of Hematologic Oncologists.血液癌症医生如何讨论预后？一项对血液肿瘤学家的全国性调查结果。
J Palliat Med. 2019 Jun;22(6):677-684. doi: 10.1089/jpm.2018.0441. Epub 2019 Mar 23.
3
Estimating the annual volume of hematologic cancer cases per hematologist-oncologist in the United States: are we treating rare cancers too rarely?估算美国每位血液肿瘤学家每年诊治的血液系统癌症病例数：我们对罕见癌症的治疗是否太少？
Leuk Lymphoma. 2017 Jan;58(1):251-252. doi: 10.1080/10428194.2016.1193854. Epub 2016 Jun 9.
4
Addressing End-of-Life Quality Gaps in Hematologic Cancers: The Importance of Early Concurrent Palliative Care.解决血液系统恶性肿瘤终末期的质量差距：早期同步姑息治疗的重要性。
JAMA Intern Med. 2016 Feb;176(2):265-6. doi: 10.1001/jamainternmed.2015.6994.
5
[Study of representations of end-of-life platelet transfusion by its protagonists: Patients, nurses and hematologic oncologists].
Bull Cancer. 2020 Dec;107(12):1241-1251. doi: 10.1016/j.bulcan.2020.08.007. Epub 2020 Oct 20.
6
Signs, Symptoms, and Characteristics Associated With End of Life in People With a Hematologic Malignancy: A Review of the Literature.血液系统恶性肿瘤患者临终时的体征、症状及相关特征：文献综述
Oncol Nurs Forum. 2016 Sep 1;43(5):E178-87. doi: 10.1188/16.ONF.E178-E187.
7
Exploring palliative care provision for recipients of allogeneic hematopoietic stem cell transplantation who relapsed.探索为复发的异基因造血干细胞移植受者提供姑息治疗。
Oncol Nurs Forum. 2014 Jul 1;41(4):370-81. doi: 10.1188/14.ONF.370-381.
8
Cancer patients and advance directives: a survey of patients in a hematology and oncology outpatient clinic.癌症患者与预先医疗指示：血液学与肿瘤学门诊患者调查
Onkologie. 2013;36(7-8):398-402. doi: 10.1159/000353604. Epub 2013 Jul 8.
9
Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China.亚太地区血液肿瘤学实践：第六届国际血液系统恶性肿瘤会议（2015年中国北京，弥合差距）的亚太血液肿瘤学大会（APHCON）调查结果
Oncotarget. 2017 Jun 20;8(25):41620-41630. doi: 10.18632/oncotarget.15655.
10
A survey of gynecologic oncologists regarding the end-of-life discussion: a pilot study.妇科肿瘤学家临终讨论调查：一项初步研究。
Gynecol Oncol. 2012 Mar;124(3):471-3. doi: 10.1016/j.ygyno.2011.09.029. Epub 2011 Oct 20.

引用本文的文献

1
Challenges in the integration of palliative care for patients with hematologic malignancies: an analysis of the surprise question in a prospective cohort study.血液系统恶性肿瘤患者姑息治疗整合中的挑战：一项前瞻性队列研究中意外问题的分析
Sao Paulo Med J. 2025 May 2;143(3):e2024263. doi: 10.1590/1516-3180.2024.0263.29012025. eCollection 2025.
2
Challenges in hospice and end-of-life care in the transfusion-dependent patient.依赖输血患者的临终关怀与终末期护理面临的挑战。
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):340-347. doi: 10.1182/hematology.2024000560.
3
Top Ten Tips Palliative Care Clinicians Should Know About Acute Myeloid Leukemia.
急性髓系白血病：姑息治疗临床医生须知的十大要点
J Palliat Med. 2024 Jun;27(6):794-801. doi: 10.1089/jpm.2023.0638. Epub 2023 Dec 8.
4
Sequencing therapy in relapsed DLBCL.复发弥漫性大 B 细胞淋巴瘤的测序治疗。
Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):146-154. doi: 10.1182/hematology.2022000332.
5
Early integration of palliative care in hematology: an urgency for patients, a challenge for physicians.血液学中姑息治疗的早期整合：对患者而言是当务之急，对医生来说是一项挑战。
Hematol Transfus Cell Ther. 2022 Oct-Dec;44(4):567-573. doi: 10.1016/j.htct.2022.06.007. Epub 2022 Jul 30.
6
Early integration of palliative care for patients with haematological malignancies.血液恶性肿瘤患者的姑息治疗的早期介入。
Br J Haematol. 2022 Oct;199(1):14-30. doi: 10.1111/bjh.18286. Epub 2022 Jun 7.
7
Pitfalls and Successes in Trials in Older Transplant Patients with Hematologic Malignancies.老年血液系统恶性肿瘤移植患者试验中的陷阱与成功之处
Curr Oncol Rep. 2022 Jan;24(1):125-133. doi: 10.1007/s11912-022-01194-3. Epub 2022 Jan 21.
8
Goal of a "Good Death" in End-of-Life Care for Patients with Hematologic Malignancies-Are We Close?终末期血液恶性肿瘤患者生存照护中“善终”的目标：我们是否接近？
Curr Hematol Malig Rep. 2021 Apr;16(2):117-125. doi: 10.1007/s11899-021-00629-1. Epub 2021 Apr 16.
9
Strategies for introducing palliative care in the management of relapsed or refractory aggressive lymphomas.复发或难治性侵袭性淋巴瘤的姑息治疗管理中的引入策略。
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):148-153. doi: 10.1182/hematology.2020000100.
10
A qualitative evidence synthesis of healthcare professionals' experiences and views of palliative care for patients with a haematological malignancy.对医疗保健专业人员在血液病恶性肿瘤患者姑息治疗方面的经验和观点的定性证据综合分析。
Eur J Cancer Care (Engl). 2020 Nov;29(6). doi: 10.1111/ecc.13316. Epub 2020 Sep 9.